hotspot -WSS

hotspot

author：Wikipedia 2025-09-29 20:52:32 - browse：38981

Alphabet’s life sciences company Verily has scored its first Centers for Disease Control and Prevention contract, a high profile job leaders hope will boost its brand in public health as well as its nascent wastewater surveillance business, executives told STAT.

Under the up-to-five year, $38 million contract, Verily will collect samples from hundreds of wastewater treatment centers across the country, analyze them for Covid-19 and the mpox virus at its South San Francisco lab, and return the data to CDC within 36 hours of collecting the samples. The contract is limited to those two pathogens but the company is prepared to analyze more if needed, leaders said.

The contract comes as Verily struggles to turn a profit among various disparate health care offerings, like value-based care analytics for health systems, clinical trial software and even an in-person substance use rehabilitation center in Ohio. Despite several prominent hires and a vast number of projects, the company has yet to forge a sustainable business.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： In age of alternative facts, a scholarly course on calling out crap
Next article： Readout Newsletter: The latest in Pfizer, Moderna, and Sanofi

focus

knowledge

WSS

UnitedHealth has 90,000 doctors — 10% of all physicians in U.S.

Cigna, Humana reportedly in talks to merge

Flagship Pioneering launches a new biotech in two countries

Organ aging and disease risk measured by new blood test

Readout LOUD podcast: A CRISPR milestone, biotech mixology

U.K. considers world's first use of meningitis vaccine to address gonorrhea

entertainment

hotspot

entertainment

Tori Bowie and the unacceptable rates of Black maternal death

FDA's Woodcock to retire early next year

The high cost of giving birth even with insurance

Readout Newsletter: The latest at Gilead, Catalent, and the NIH

23andMe had bad news about my health. I wish a person had delivered it

Will the market for weight loss drugs really reach $100 billion?

FDA approval of Sarepta Duchenne genetic therapy gives me hope

How to pay for weight loss drugs and save Medicare

Cancer drug shortages should be causing more outrage

Astellas still sees hope in its gene therapy after four deaths

focus

How to pay for weight loss drugs and save Medicare

U.K. considers world's first use of meningitis vaccine to address gonorrhea

A daunting task: navigating dual Medicare, Medicaid eligibility

Diagnostic tests are hitting their mathematical limits

World's first CRISPR

U.K. considers world's first use of meningitis vaccine to address gonorrhea

hotspot

focus

knowledge

leisure time